Abstract
Traditionally, heart failure has been thought secondary to impaired left ventricular pump performance. According to this view, systolic dysfunction is secondary to contractile failure. Recently, a new view of heart failure has been developed where systolic dysfunction is thought secondary to a structural increase in ventricular chamber volume. Instead of contractile failure leading to chamber dilatation, chamber dilatation occurs as an early response that results in decreased wall motion that is mandated to generate a normal stroke volume from a larger end-diastolic volume. Remodeling is the term used to refer to the pathologic change in chamber length and shape, not related to a preload-mandated increase in sacromere length. As the heart remodels and dilates, the radius of curvature increases, increasing wall tension, leading to increased myocardial oxygen consumption, decreased subendocardial blood flow, impaired energetics, and increased arrhythmias. Overall, poor prognosis directly correlates with the degree of remodeling (1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cohn JN, Ferrari R, Sharpe N, on behalf of an International Forum on Cardiac Remodeling. Cardiac remodeling-concept and clinical implications: a consensus paper. J Am Coll Cardiol 2000;35:569–582.
Transplant Patient Data Source (2001, May 11). Richmond, VA. United Network for Organ Sharing. Retrieved May 11, 2001 from the World Wide Web: http://www.patients.unos.org/data.htm
Pagano D, Bonser RS, Camici PG. Myocardial revascularization for the treatment of post-ischemic heart failure. Curr Opin Cardiol 1999;14:506–509.
Trachiotis GD, Weintraub WS, Johnston TS, et al. Coronary artery bypass grafting in patients with advanced left ventricular dysfunction. Ann Thorac Surg 1998;66:1632–1639.
Dreyfus GD, Duboc D, Blasco A, et al. Myocardial viability assessment in ischemic cardiomyopathy: benefits of coronary revascularization. Ann Thorac Surg 1994;57:1402–1407.
Tjan TD, Kondruweit M, Scheld HH, et al. The bad ventricle-revascularization versus transplantation. Thorac Cardiovasc Surg 2000;48:9–14.
Lansman SL, Cohen M, Galla JD, et al. Coronary bypass with ejection fraction of 0.20 or less using centigrade cardioplegia: long-term follow-up. Ann Thorac Surg 1993;56:480–485.
Kaul TK, Agnihotri AK, Fields BL, et al. Coronary artery bypass grafting in patients with an ejection fraction of twenty percent or less. J Thorac Cardiovasc Surg 1996;111:1001–1012.
Hendren WG, Nemec JJ, Lytle BW, et al. Mitral valve repair for ischemic mitral insufficiency. Ann Thorac Surg 1991;52:1246–1251.
Bolling SF, Pagani FD, Deeb GM, Bach DS. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg 1998;115:381–386.
Smolens IA, Pagani FD, Bolling SF. Mitral valve repair in heart failure. Eur J Heart Fail 2000;2:365–371.
Sintek CF, Pfeffer TA, Kochamba G, et al. Preservation of normal left ventricular geometry during mitral valve replacement. J Heart Valve Dis 1995;4:471–475.
Sarris GE, Cahill PD, Hansen DE, et al. Restoration of left ventricular systolic performance after reattachment of the mitral chordae tendineae. The importance of valvular-ventricular interaction. J Thorac Cardiovasc Surg 1988;95:969–979.
Natsuaki M, Itoh T, Tomita S, et al. Importance of preserving the mitral subvalvular apparatus in mitral valve replacement. Ann Thorac Surg 1996;61:585–590.
Komeda M, David TE, Rao V, et al. Late hemodynamic effects of the preserved papillary muscles during mitral valve replacement. Circ 1994;90:11190–194.
Batista RJ, Santos JL, Takeshita N, et al. Partial left ventriculectomy to improve left ventricular function in end-stage heart disease. J Card Surg 1996;11:96, 97.
Batista RJ, Verde J, Nery P, et al. Partial left ventriculectomy to treat end-stage heart disease. Ann Thorac Surg 1997;64:634–638.
McCarthy JF, McCarthy PM, Starling RC, et al. Partial left ventriculectomy and mitral valve repair for end-stage congestive heart failure. Eur J Cardiothorac Surg 1998;13:337–343.
Etoch SW, Koenig SC, Laureano MA, et al. Results after partial left ventriculectomy versus heart transplantation for idiopathic cardiomyopathy. J Thorac Cardiovasc Surg 1999;117:952–959.
Dor V, Saab M, Coste P, et al. Left ventricular aneurysm: a new surgical approach. Thorac Cardiovasc Surg 1989;37:11–19.
Athanasuleas CL, Stanley AW Jr, Buckberg GD, et al. Surgical anterior ventricular endocardial restoration (SAVER) in the dilated remodeled ventricle after anterior myocardial infarction. RESTORE group. Reconstructive Endoventricular Surgery, returning Torsion Original Radius Elliptical Shape to the LV. J Am Coll Cardiol 2001;37:1199–1209.
Dor V, Sabatier M, Di Donato M, et al. Efficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left ventricular dysfunction: comparison with a series of large dyskinetic scars. J Thorac Cardiovasc Surg 1998;116:50–59.
Di Donato M, Sabatier M, Dor V, et al. Effects of the Dor procedure on left ventricular dimension and shape and geometric correlates of mitral regurgitation one year after surgery. J Thorac Cardiovasc Surg 2001;121:91–96.
Sabbah HN, Sharov VG, Chaudhry PA, et al. Chronic therapy with the Acorn Cardiac Support Device in dogs with chronic heart failure: three and six months hemodynamic, histologic and ultrastructural findings (abstr). J HeartLung Transplant 2001;20:189.
Sabbah HN, Gupta RC, Sharov VG, et al. Prevention of progressive left ventricular dilation with the Acorn Cardiac Support Device down regulates stretch-response proteins and improves sarcoplasmic reticulum recycling in dogs with chronic heart failure (abstr). J Am Coll Cardiol 2001;1:37:474A.
Saavedra F, Tunin R, Mishima T, et al. Reverse remodeling and enhanced adrenergic reserve from a passive external ventricular support in experimental dilated heart failure (abstr). Circulation 2000;102:11:501.
Sabbah HN, Gupta RC, Sharov VG, et al. Prevention of progressive left ventricular dilation with the Acorn Cardiac Support Device (CSD) down regulates stretchmediated p2 1 ras. attentuates myocyte hypertrophy and improves sarcoplasmic reticulum calcium cycling in dogs with heart failure (abstr). Circulation 2000;102:11–683.
Chaudry PA, Mishima T, Sharov VG, et al. Passive epicardial containment prevents ventricular remodeling in heart failure. Ann Thor Surg 2000;70:1275–1280.
Gupta RC, Sharov VG, Mishra S, et al. Chronic therapy with the Acorn Cardiac Support Device (CSD) attentuates cardiomyocyte apoptosis in dogs with heart failure (abstr). J Am Coll Cardiol 2001;1:37:478A.
Kleber FX, Sonntag S, Krebs H, et al. Follow-up on passive cardiomyoplasty in congestive heart failure: influence on the Acorn Cardiac Support Device on left ventricular function (abstr). J Am Coll Cardiol 2001;3737:143A.
Pilla JJ, Brockman DJ, Blom AS, et al. Prevention of dilatation using the Acorn cardiac support devise (CSD) results in reversed remodeling and improvement of function. (Poster) American Heart Association, Scientific Session 2001, Anaheim, CA, Nov. 2001.
Pilla JJ, Blom AS, Brockman DJ, et al., Ventricular constraint using the Acorn cardiac support device (CSD) limits infarct expansion. (Poster) American American Heart Association, Scientific Session 2001, Anaheim, CA, Nov. 2001.
Goldstein DJ, Oz MC. Mechanical support for postcardiotomy cardiogenic shock. Semin Thorac Cardiovasc Surg 2000;12:220–228.
McCarthy PM, Portner PM, Tobler HG, et al. Clinical experience with the Novacor ventricular assist system. Bridge to transplantation and the transition to permanent application. J Thorac Cardiovasc Surg 1991;102:578–586.
Levin HR, Chen JM, Oz MC, et al. Potential of left ventricular assist devices as outpatient therapy while awaiting transplantation. Ann Thorac Surg 1994;58:1515–1520.
Sun BC, Catanese KA, Spanier TB, et al. 100 long-term implantable left ventricular assist devices: the Columbia Presbyterian interim experience. Ann Thorac Surg 1999;68:688–694.
Muller J, Wallukat G, Weng YG, et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation 1997;15;96:542–549.
Mancini DM, Beniaminovitz A, Levin H, et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 1998;98:2383–2389.
McCarthy RE, Boehmer JP, Hruban RH, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000;342:690–695.
Acker MA. Mechanical circulatory support for patients with acute/fulminant myocarditis. Ann Thorac Surg discussion S82–85, 2001;71:S73–76.
Rose EA, Moskowitz AJ, Packer M, discussion S82–5, The REMATCH trial: rationale, design, and end points. Randomized evaluation of mechanical assistance for the treatment of congestive heart failure. Ann Thorac Surg 1999;67:723–730.
Mann DL, Willerson JT. Left ventricular assist devices and the failing heart: abridge to recovery, a permanent assist device, or a bridge too far? Circulation 1998;98:2367–2369.
Frazier OH. Future directions of cardiac assistance. Semin Thorac Cardiovasc Surg 2000;12:220–228.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Zeltsman, D., Acker, M.A. (2003). Emerging Therapies in Heart Failure. In: Jessup, M.L., Loh, E. (eds) Heart Failure. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-347-7_16
Download citation
DOI: https://doi.org/10.1007/978-1-59259-347-7_16
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4684-9759-5
Online ISBN: 978-1-59259-347-7
eBook Packages: Springer Book Archive